Your session is about to expire
← Back to Search
Lipase Inhibitor
Orlistat for Polybrominated Biphenyl Poisoning
Phase 4
Waitlist Available
Led By Michele Marcus, PhD/MPH
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screening, 3 and 6 months follow up visits
Awards & highlights
Study Summary
This study is evaluating whether a drug used to help with weight loss may also help reduce the body burden of certain chemicals.
Eligible Conditions
- Polybrominated Biphenyl Poisoning
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ screening, 3 and 6 months follow up visits
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening, 3 and 6 months follow up visits
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Body Mass Index
Change in weight
Secondary outcome measures
Change in dietary intake using Automated Self-administered 24-hour Recall score
Change in physical activity
Change in serum concentration of PCB 138
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Orlistat Weight Loss AidExperimental Treatment2 Interventions
Participants randomized to take orlistat at the over-the-counter dose for six months. Diet and exercise plus a daily multivitamin will also be recommended and monitored.
Group II: PlaceboPlacebo Group2 Interventions
Participants randomized to take a placebo to match orlistat at the over-the-counter dose for six months. Diet and exercise plus a daily multivitamin will also be recommended and monitored.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Multivitamin
2016
Completed Phase 4
~20750
Orlistat
2022
Completed Phase 4
~1490
Find a Location
Who is running the clinical trial?
National Institute of Environmental Health Sciences (NIEHS)NIH
283 Previous Clinical Trials
1,232,137 Total Patients Enrolled
Michigan Public Health DepartmentsUNKNOWN
Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,530 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger